Health

Companies engaged in biotechnology, pharmaceuticals, research services, home healthcare, hospital operations, long‑term care, and the manufacture and supply of medical equipment and supplies. The sector also includes pharmaceutical retailers and providers of health‑information services. UK‑listed companies in this sector include AstraZeneca plc, GlaxoSmithKline plc, Smith & Nephew plc, Hikma Pharmaceuticals plc, ConvaTec Group plc, Spire Healthcare plc and EMIS Group plc.

Poolbeg Pharma creating demonstrable value

Poolbeg Pharma plc (LON:POLB) a clinical stage infectious disease pharmaceutical company with a unique capital light clinical model, has announced that its Annual Report and Accounts for the period ended..

Open Orphan to open new facilities and double volunteer recruitment screening capacity

Open Orphan plc (LON:ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, has provided a..

Goodbody Health rolls out blood testing technology

Goodbody Health Inc (AQSE:GDBY) has announced that, following a successful pilot project using new technology to deliver accessible, fast (available in less than 10 minutes) blood test results in the..

Oncimmune Holdings follow-on contract signed with leading US medical research organisation

Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, today announced the signing of a new commercial follow-on contract with a world-leading medical research organisation based in the US, to..

Cizzle Biotechnology report further positive outcomes from the Arcadia Clinical Trial

Cizzle Biotechnology Holdings plc (LON:CIZ), the UK-based diagnostics developer, has reported that St George Street Capital has provided an update on the further analysis of data from the ARCADIA clinical..

Oncimmune ImmunoINSIGHTS contract signed with leading top 10 global pharmaceutical company

Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, has today announced the signing of a commercial contract with a new top 10 global pharmaceutical company by revenue, initially focusing..

Goodbody Health announces Normal Course Issuer Bid and Restricted Share Unit Plan

Goodbody Health Inc (AQSE: GDBY) has today announced (i) its intention to initiate a normal course issuer bid (“NCIB“) through the facilities of the Canadian Securities Exchange; and (ii) the..

Poolbeg Pharma reports a period of great progress

Following on from Poolbeg Pharma plc (LON:POLB) audited results for the period ended 31 December 2021, DirectorsTalk Interviews caught up with Chairman Cathal Friel for his thoughts on the update...

Allergy Therapeutics shares positive new data at 2022 American Academy of Allergy Asthma

Allergy Therapeutics plc (LON:AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, has announced the presentation of positive new data from its two lead immunotherapy programmes at the..

Goodbody Health early detection substantially improves patient outcomes (Interview)

Goodbody Health Inc. (CSE: GDBY / AQSE: GDBY / FRA: 484 / OTC: SCNNF) Scientific Advisory Committee Member Dr Jamie Brosch joins DirectorsTalk Interviews to share his views on the..

Goodbody Health rolling out blood testing through its existing network of clinics

Goodbody Health Inc. (AQSE:GDBY) has announced the rollout of its plan to introduce blood testing through its existing network of clinics while it continues to contract with more new pharmacies..

Goodbody supports NHS health crusade with cholesterol tests

The NHS has announced that it has launched a new lifesaving campaign to encourage people to dial 999 when they are having early signs of a heart attack. With backers..

Oncimmune Holdings further contract signed with leading, top five global pharmaceutical company

Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, has today announced it has signed a further commercial contract under its existing master services agreement with a top five global..

Goodbody Health’s PhytoVista in a good place in terms of meeting current and future regulatory requirements (AQSE:GDBY)

Goodbody Health Group Inc (AQSE:GDBY) subsidiary PhytoVista Laboratories Chief Scientific Officer Nick Clarkson caught up with DirectorsTalk for an exclusive interview to discuss the extension of the scope of ISO..

Goodbody Health to help prevent type 2 diabetes through blood glucose level checks

Prediabetes is a serious health condition where blood sugar levels are higher than usual, but not high enough yet for a type 2 diabetes diagnosis. According to Diabetes UK, at..

Blood testing opens up market for early Cancer detection

The Sunday Times reported on the 6 February 2022 that a new blood testing technique due to be introduced by the NHS will determine how likely a patient is to..

Goodbody Health to seize upon £690 million legal UK CBD market

We’re on the verge of the biggest shake-up of the UK’s consumer health sector in relation to cannabinoid products (CBD).  The Association for the Cannabinoid Industry (ACI) announced in a..

Goodbody Health aligned with NICE innovation agenda

The Board of The National Institute for Health and Care Excellence (NICE), provided an update on 20 January 2022 on how it plans to evaluate promising new health technologies and..

Why getting your prostate checked is so important

The prostate is a small gland in the pelvis and is part of the male reproductive system. Prostate cancer begins when cells in the prostate gland start to grow out..

Allergy Therapeutics announces FDA clearance for novel peanut allergy vaccine candidate

Allergy Therapeutics plc (LON:AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, today announced that the United States Food & Drug Administration (FDA) has cleared the Group’s Investigational..

Search

Funds

Health

Search

Funds

Health

FTSE 100

Funds